Clinical Trial: Investigational Drug versus an Approved Drug in Patients with Osteoarthritis

This study is no longer recruiting patients.

Sponsored by: Merck
Information provided by: Merck

Purpose

The purpose of this study is to compare the gastrointestinal tolerability of an investigational drug to an approved drug in the treatment of osteoarthritis during one year treatment period.

Condition Treatment or Intervention Phase
Osteoarthritis
 
Phase II
Phase III

MedlinePlus related topics:  Osteoarthritis

Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Parallel Assignment, Safety Study

Official Title: A Study to Evaluate the Tolerability and Effectiveness of an Investigational Drug versus an Approved Drug in Patients with Osteoarthritis

Eligibility

Ages Eligible for Study:  50 Years and above,  Genders Eligible for Study:  Both

Criteria

Inclusion Criteria:

  • Osteoarthritis of the knee, hip, hand or spine which requires the use of medications for pain relief

Exclusion Criteria:

  • Known allergies to the study drugs

Location Information


Pennsylvania
      Call for Information, Horsham,  Pennsylvania,  19044,  United States

More Information

Study ID Numbers:  2004_052
Record last reviewed:  September 2004
Last Updated:  October 13, 2004
Record first received:  September 23, 2004
ClinicalTrials.gov Identifier:  NCT00092703
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005

Resources